Daniel Chen
Molecular Biology · with Apte · 2019
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 31 citations into it
- Oncology — 22 citations into it
- Cancer Research — 17 citations into it
Whom Daniel Chen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Daniel Chen's perspective
Ordered by how strongly the researchers Daniel Chen trusts endorse each paper. Same corpus, a different order for every researcher.
- Basic and therapeutic aspects of angiogenesis. (Cell)
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system (Nature reviews. Molecular cell biology)
- Molecular regulation of vessel maturation (Nature Medicine)
- Deciphering and reversing tumor immune suppression. (Immunity)
- Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. (Cancer Research)
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
- Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
- AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. (Cancer Cell)
- Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. (Cell)
- VEGF receptor signalling ? in control of vascular function (Nature reviews. Molecular cell biology)
Their papers
- VEGF in Signaling and Disease: Beyond Discovery and Development (2019) — 2,318 citations